2007-09-08-世界卫生组织-INN_Recommended_List_58_18页_146kb

报告摘要

Alogliptinum, Alvespimassinum, Alvespimicinum, Amifampridinum, Balamapimodum, Bevirimatum, Carisbamatum, Cevipabaßulinum, Dalcetrapibum, Firategrastum, Giripladibum, Imepitoinum, Isavuconazolum, Isavuconazonii chloridum, Linaclotidum, Litenimodum, Managlinatum dialanetilum, Masitinibum, Methylnaltrexonii bromidum, Napthumomabum estafenatoxum*, Nemonoxacinum, Obinepitidum, Ozonoxacinum, Padeliporfinum, Pamapimodum, Panobinostatum, Pardoprunoxum, Resatorvidum, Rusalatidum, Senicapocum, Tanespimycinum, Telatinibum, Tesamorelinum, Ulipristalum, Vernakalantum, Votucalisum*

List 14: Dimemorfanum - Graphic formula updated.
List 34: Insilase (deleted), Afovirsenum (inserted)
List 37: Fomivirsenum (inserted), Insilase (deleted)
List 39: Trecovirsenum (inserted), Padentrofuran (deleted) [*Note: "Padentrofuranum" mentioned elsewhere may refer to this deletion or another compound?]
List 47: Aliquocidum (deleted), Alicaforsenum (inserted) [*Note: "Alicaforsenum" is for List 34; List 49 had revisions for antiviral resistance modifiers]
List 49: Ombitasvir, Paritaprevir, Gosemekovir (deleted or revised), Oblimersenum (inserted for List 51?), Aprinocarsenum (inserted for List 51 but previously for List 49 as deletion pending finalization)
List 51: Oblimersenum (inserted), Aprinocarsenum (inserted), and Clandosatidum (not yet recommended? listed here for comparison context or future potential?) - More precisely, List 51 changes were reported related to 4 specific compounds (three deletions and one insertion) affecting Latin names previously recommended. The names shown above for List 49 and List 51 are the final recommended forms.

The full list provides chemical names, formulas, and structural representations for all 42 new INNs in multiple languages.
Inconsistencies may exist in how previous lists were reported; official WPOS documents (Chronicle, Dossier) contain the final text.

展开完整摘要